查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965427

近視和老花眼治療市場－全球產業規模、佔有率、趨勢、機會和預測：按近視治療類型、老花眼治療類型、地區和競爭格局分類，2021-2031年

Myopia And Presbyopia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Myopia Treatment Type, By Presbyopia Treatment Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球近視和老花眼治療市場預計將從 2025 年的 219.5 億美元大幅成長到 2031 年的 353.8 億美元，複合年成長率為 8.28%。

該行業涵蓋多種矯正視力解決方案，包括處方眼鏡、隱形眼鏡、屈光矯正手術以及用於矯正近視和老齡化視力下降的藥物。該行業的成長主要受人口結構變化驅動，例如全球人口老化以及與生活方式因素（如電子設備使用增加和戶外活動減少）相關的近視盛行率上升。此外，人們對擺脫眼鏡依賴的強烈潛在需求也大力推動了現代矯正技術的普及。例如，隱形眼鏡研究所2024年的數據顯示，47.8%從未嘗試過隱形眼鏡的眼鏡配戴者對隱形眼鏡表現出濃厚的興趣，這表明隱形眼鏡市場具有巨大的滲透潛力。

市場概覽
預測期 2027-2031
市場規模：2025年 219.5億美元
市場規模：2031年 353.8億美元
複合年成長率：2026-2031年 8.28%
成長最快的細分市場 處方箋
最大的市場 北美洲

然而，尤其是在新興經濟體，由於先進矯正治療費用高且供應有限，人們獲得這些治療存在許多障礙。高品質的屈光矯正手術和專用治療設備需要大量投資，這限制了其普及，使其主要面向富裕人群，並阻礙了醫療基礎設施不足的發展中地區的成長。因此，儘管存在需求，但經濟壁壘阻礙了這些市場的擴張。

市場促進因素

全球近視和老花眼盛行率的不斷上升正在從根本上改變治療格局，並成為市場成長的主要驅動力。這一激增與快速都市化和過度使用電子設備等生活方式因素密切相關，加速了年輕一代屈光不正的發生。因此，人們越來越迫切地需要超越傳統矯正眼鏡的有效管理策略，這促使了專用控制鏡片和介入療法的出現。為了因應這項重大的公共衛生挑戰，英國驗光師協會在2024年10月發表的報導《檢驗近視的全球蔓延》中指出，研究人員估計目前全球兒童和青少年近視盛行率為30.47%。這一數字敦促製造商加快創新步伐。

同時，新型藥物療法和矯正眼藥水的出現，患者照護帶來了革命性的變革，為手術和眼鏡提供了非侵入性的替代方案。近期老花眼矯正眼藥水和低劑量阿托品近視眼藥水的商業化，標誌著視力障礙藥物治療領域的一次重大轉變，而大量資金的流入也為這些解決方案的商業化提供了支持。例如，《驗光時報》在2024年10月報道稱，Orasis Pharmaceuticals公司已獲得7,800萬美元的資金籌措，用於支持其眼藥水「Qlosi」的商業化。這種強勁的投資環境凸顯了該產業的財務活力，而美國視覺委員會的一份報告顯示，2024年美國光學產業的總市值達到了683億美元。

市場挑戰

先進正畸治療的高昂費用和有限的普及程度是全球市場擴張的主要障礙。昂貴的屈光矯正手術和特殊藥物帶來的高昂經濟門檻，使得這些解決方案僅限於富裕人群。這種經濟差距阻礙了大眾市場，尤其是在開發中國家，從傳統的低成本矯正方法（例如普通眼鏡）過渡到先進矯正治療。因此，儘管先進正畸治療具有臨床益處，但由於絕大多數患者無力承擔現代治療所需的高額自付費用，其潛在市場規模被人為地限制了。

選擇性手術的高昂費用加劇了這項挑戰，因為這些費用通常不在綜合保險的覆蓋範圍內。根據屈光矯正手術)的數據，2024 年雙眼 LASIK 雷射近視手術的平均費用約為 4,400 美元。如此高昂的價格在新興經濟體中構成了一大障礙，因為這些地區的居民可支配收入有限，醫療基礎設施往往不足以支持廣泛獲得這些專業治療。因此，這些高成長地區的市場滲透率仍然緩慢，阻礙了整個行業的整體收入成長。

市場趨勢

新一代近視控制眼鏡鏡片的普及，正在為兒童患者建立一種超越傳統單焦點矯正的新治療標準。這些先進的鏡片採用特殊的光學散焦技術，能夠主動抑制眼球伸長，這與僅矯正屈光不正的普通眼鏡截然不同。臨床證據證實了其有效性，推動了這一轉變，並加速了其作為主要非侵入性干預手段的普及。這些產品的商業性成功凸顯了其在治療方案中日益成長的重要性。根據依視路陸遜梯卡集團於2025年2月發布的2024年第四季/全年新聞稿，其在中國的立體鏡片銷量在第四季度成長了約50%。

同時，植入式膠原蛋白晶體（ICL）技術的進步正不斷擴大，成為高度近視患者（不適合接受角膜雷射手術）的一種手術選擇。這反映了技術從LASIK等減法手術轉向能夠保護角膜完整性的加法手術的轉變。製造商透過擴大這些醫療設備的屈光矯正範圍，提高了外科醫師的信心和病患的接受度。隨著手術數量的增加，該行業取得了強勁的財務業績。根據STAAR Surgical於2025年10月發布的題為「STAAR Surgical公佈2025年第三季初步淨銷售額」的新聞稿，該公司初步淨銷售額為9,470萬美元，年增6.9%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：近視與老花眼治療的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 近視治療方法（矯正、手術和藥物）
    • 老花眼治療方法（處方箋、隱形眼鏡、人工水晶體、屈光矯正手術）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美近視與老花眼治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲近視與老花眼治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區近視與老花眼治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲近視和老花眼治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲近視與老花眼治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球近視與老花眼治療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ziemer Ophthalmic Systems AG
  • NIDEK CO., LTD.
  • Johnson & Johnson Vision
  • EssilorLuxottica.
  • ZEISS Group
  • Alcon Vision LLC
  • Bausch+Lomb Corporation
  • Haag-Streit UK
  • Topcon Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20933

The Global Myopia And Presbyopia Treatment Market is projected to expand significantly, growing from USD 21.95 Billion in 2025 to USD 35.38 Billion by 2031, reflecting a compound annual growth rate of 8.28%. This industry encompasses a broad range of corrective medical solutions, including prescription eyeglasses, contact lenses, refractive surgeries, and pharmacological agents designed to rectify nearsightedness and age-related vision loss. The sector's growth is primarily fueled by demographic shifts, such as an aging global population, and the rising prevalence of myopia linked to lifestyle factors like increased digital consumption and reduced outdoor activity. Additionally, a strong latent consumer demand for spectacle independence serves as a powerful catalyst for adopting modern corrective technologies; for instance, 2024 data from the Contact Lens Institute indicated that 47.8 percent of glasses wearers who had never tried contact lenses were highly interested in doing so, revealing a substantial opportunity for market penetration.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 21.95 Billion
Market Size 2031USD 35.38 Billion
CAGR 2026-20318.28%
Fastest Growing SegmentPrescription
Largest MarketNorth America

However, the market faces a significant hurdle regarding the prohibitive cost and limited accessibility of advanced corrective procedures, particularly in emerging economies. The substantial financial investment required for premium refractive surgeries and specialized management devices restricts their adoption largely to wealthier demographics, thereby slowing growth in developing regions where healthcare infrastructure is less established. Consequently, while demand exists, economic barriers prevent broader expansion in these markets.

Market Driver

The escalating global prevalence of myopia and presbyopia is fundamentally reshaping the treatment landscape and serving as a primary catalyst for market growth. This surge is increasingly connected to lifestyle factors such as rapid urbanization and intense digital consumption, which have accelerated the onset of refractive errors in younger demographics. As a result, there is a heightened urgency for effective management strategies that go beyond traditional corrective eyewear, driving the adoption of specialized control lenses and interventions. Underscoring this critical public health challenge, the Association of Optometrists reported in their October 2024 article, 'Examining the global prevalence of myopia,' that researchers estimated the current global prevalence of myopia among children and young people to be 30.47%, a figure that is compelling manufacturers to innovate rapidly.

Concurrently, the emergence of novel pharmacological therapies and corrective eye drops is revolutionizing patient care by offering non-invasive alternatives to surgery and spectacles. Recent commercial launches of presbyopia-correcting drops and low-dose atropine for myopia indicate a significant shift toward pharmaceutical management of vision impairment, supported by substantial capital inflows aimed at commercializing these solutions. For example, Optometry Times reported in October 2024 that Orasis Pharmaceuticals secured $78 million in financing to support the commercial launch of Qlosi. This robust investment climate highlights the sector's financial vitality, further evidenced by The Vision Council's report that the U.S. optical industry achieved a total market value of $68.3 billion in 2024.

Market Challenge

The prohibitive cost and limited accessibility of advanced corrective procedures constitute a primary obstruction to the expansion of the global market. High financial barriers associated with premium refractive surgeries and specialized pharmacological agents effectively restrict the adoption of these solutions to affluent demographics. This economic stratification prevents the mass market, particularly in developing nations, from transitioning away from traditional, lower-cost correctives like standard eyeglasses. Consequently, the addressable market size is artificially capped, as a vast majority of the patient population cannot afford the significant out-of-pocket leverage required for modern interventions, despite the clinical benefits they offer.

This challenge is exacerbated by the substantial price tag attached to elective procedures, which often lack comprehensive insurance coverage. According to the Refractive Surgery Council, in 2024, the average cost of LASIK eye surgery was approximately $4,400 for a bilateral procedure. Such a high price point is prohibitive in emerging economies where disposable income is limited and healthcare infrastructure is often insufficient to support widespread access to such specialized treatments. As a result, market penetration in these high-growth potential regions remains sluggish, hampering the overall revenue trajectory of the industry.

Market Trends

The proliferation of next-generation myopia control spectacle lenses is establishing a new standard of care for pediatric patients, moving beyond traditional single-vision correction. These advanced lenses utilize specialized optical defocus technologies to actively slow eyeball elongation, contrasting with standard glasses that merely correct refractive error. This shift is driven by clinical evidence of their efficacy, prompting adoption as a primary non-invasive intervention. The commercial success of these products highlights their growing importance in the treatment mix; according to EssilorLuxottica's 'Q4/Full Year 2024 Results' press release in February 2025, revenue for Stellest lenses increased by approximately 50% in China during the fourth quarter.

Advancements in Implantable Collamer Lens (ICL) technologies are simultaneously expanding surgical options for high myopia patients often unsuitable for corneal laser procedures. This reflects a technological pivot from subtractive techniques like LASIK to additive solutions that preserve corneal integrity. Manufacturers are enhancing these devices with wider refractive ranges, increasing surgeon confidence and patient acceptance. This segment is witnessing robust financial performance as procedure volumes rise; according to the 'STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025' press release in October 2025, the company reported preliminary net sales of $94.7 million, representing a 6.9% increase compared to the prior year period.

Key Market Players

  • Ziemer Ophthalmic Systems AG
  • NIDEK CO., LTD.
  • Johnson & Johnson Vision
  • EssilorLuxottica.
  • ZEISS Group
  • Alcon Vision LLC
  • Bausch + Lomb Corporation
  • Haag-Streit UK
  • Topcon Corporation

Report Scope

In this report, the Global Myopia And Presbyopia Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Myopia And Presbyopia Treatment Market, By Myopia Treatment Type

  • Corrective
  • Surgical
  • Drugs

Myopia And Presbyopia Treatment Market, By Presbyopia Treatment Type

  • Prescription
  • Contact Lenses
  • Intraocular Lenses
  • Refractive Surgery

Myopia And Presbyopia Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Myopia And Presbyopia Treatment Market.

Available Customizations:

Global Myopia And Presbyopia Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Myopia And Presbyopia Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Myopia Treatment Type (Corrective, Surgical, Drugs)
    • 5.2.2. By Presbyopia Treatment Type (Prescription, Contact Lenses, Intraocular Lenses, Refractive Surgery)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Myopia And Presbyopia Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Myopia Treatment Type
    • 6.2.2. By Presbyopia Treatment Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Myopia And Presbyopia Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Myopia Treatment Type
        • 6.3.1.2.2. By Presbyopia Treatment Type
    • 6.3.2. Canada Myopia And Presbyopia Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Myopia Treatment Type
        • 6.3.2.2.2. By Presbyopia Treatment Type
    • 6.3.3. Mexico Myopia And Presbyopia Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Myopia Treatment Type
        • 6.3.3.2.2. By Presbyopia Treatment Type

7. Europe Myopia And Presbyopia Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Myopia Treatment Type
    • 7.2.2. By Presbyopia Treatment Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Myopia And Presbyopia Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Myopia Treatment Type
        • 7.3.1.2.2. By Presbyopia Treatment Type
    • 7.3.2. France Myopia And Presbyopia Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Myopia Treatment Type
        • 7.3.2.2.2. By Presbyopia Treatment Type
    • 7.3.3. United Kingdom Myopia And Presbyopia Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Myopia Treatment Type
        • 7.3.3.2.2. By Presbyopia Treatment Type
    • 7.3.4. Italy Myopia And Presbyopia Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Myopia Treatment Type
        • 7.3.4.2.2. By Presbyopia Treatment Type
    • 7.3.5. Spain Myopia And Presbyopia Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Myopia Treatment Type
        • 7.3.5.2.2. By Presbyopia Treatment Type

8. Asia Pacific Myopia And Presbyopia Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Myopia Treatment Type
    • 8.2.2. By Presbyopia Treatment Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Myopia And Presbyopia Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Myopia Treatment Type
        • 8.3.1.2.2. By Presbyopia Treatment Type
    • 8.3.2. India Myopia And Presbyopia Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Myopia Treatment Type
        • 8.3.2.2.2. By Presbyopia Treatment Type
    • 8.3.3. Japan Myopia And Presbyopia Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Myopia Treatment Type
        • 8.3.3.2.2. By Presbyopia Treatment Type
    • 8.3.4. South Korea Myopia And Presbyopia Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Myopia Treatment Type
        • 8.3.4.2.2. By Presbyopia Treatment Type
    • 8.3.5. Australia Myopia And Presbyopia Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Myopia Treatment Type
        • 8.3.5.2.2. By Presbyopia Treatment Type

9. Middle East & Africa Myopia And Presbyopia Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Myopia Treatment Type
    • 9.2.2. By Presbyopia Treatment Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Myopia And Presbyopia Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Myopia Treatment Type
        • 9.3.1.2.2. By Presbyopia Treatment Type
    • 9.3.2. UAE Myopia And Presbyopia Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Myopia Treatment Type
        • 9.3.2.2.2. By Presbyopia Treatment Type
    • 9.3.3. South Africa Myopia And Presbyopia Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Myopia Treatment Type
        • 9.3.3.2.2. By Presbyopia Treatment Type

10. South America Myopia And Presbyopia Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Myopia Treatment Type
    • 10.2.2. By Presbyopia Treatment Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Myopia And Presbyopia Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Myopia Treatment Type
        • 10.3.1.2.2. By Presbyopia Treatment Type
    • 10.3.2. Colombia Myopia And Presbyopia Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Myopia Treatment Type
        • 10.3.2.2.2. By Presbyopia Treatment Type
    • 10.3.3. Argentina Myopia And Presbyopia Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Myopia Treatment Type
        • 10.3.3.2.2. By Presbyopia Treatment Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Myopia And Presbyopia Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ziemer Ophthalmic Systems AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. NIDEK CO., LTD.
  • 15.3. Johnson & Johnson Vision
  • 15.4. EssilorLuxottica.
  • 15.5. ZEISS Group
  • 15.6. Alcon Vision LLC
  • 15.7. Bausch + Lomb Corporation
  • 15.8. Haag-Streit UK
  • 15.9. Topcon Corporation

16. Strategic Recommendations

17. About Us & Disclaimer